FiercePharma takes a holiday

FiercePharma won't be published Monday, Jan. 16, as we honor Dr. Martin Luther King Jr. We're hoping you get the opportunity to do the same. Look for our next issue on Tuesday for late-breaking pharma news. - Liz Hollis (email | twitter)

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.